Literature DB >> 31496155

[Advanced treatment time improves outcomes of patients with ischemic stroke undergoing reperfusion therapy].

Hongfang Chen1, Xiaoxian Gong2, Dongjuan Xu3, Zhimin Wang4, Haifang Hu5, Chenglong Wu6, Xiaoling Zhang7, Xiaodong Ma8, Yaxian Wang9, Haitao Hu2, Min Lou2, Zhicai Chen2.   

Abstract

OBJECTIVE: To investigate the effect of treatment time on the outcome of patients with ischemic stroke undergoing reperfusion therapy.
METHODS: The clinical data of 3229 ischemic stroke patients who received intravenous thrombolysis with or without arterial thrombolysis from 71 hospitals in Zhejiang province from June 2017 to September 2018 were retrospectively reviewed. The good outcome was defined as modified Rankin Scale (mRS) ≤ 2. Binary logistic regression analysis was used to investigate the association of door to needle time (DNT), or door to reperfusion time (DRT) with the outcomes in patients treated by intravenous thrombolysis or bridging arterial thrombolysis, respectively.
RESULTS: Binary logistic regression showed that DNT (OR=0.994, 95%CI:0.991-0.997, P<0.01) or DRT (OR=0.989, 95%CI:0.983-0.995, P<0.01) were independently associated with good outcomes, respectively. Every hour decreases in DNT resulted in a 4.7%increased probability of functional independence (mRS 0-2) in patients treated by intravenous thrombolysis; Every hour decreases in DRT was associated with a 11.4%increased probability of functional independence in patients treated by intravenous thrombolysis with arterial thrombolysis.
CONCLUSIONS: Good outcomes are associated with lower DNT in ischemic stroke patients treated by intravenous thrombolysis or lower DRT in patients treated by intravenous thrombolysis bridging arterial thrombolysis.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31496155      PMCID: PMC8800796          DOI: 10.3785/j.issn.1008-9292.2019.06.03

Source DB:  PubMed          Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban        ISSN: 1008-9292


  13 in total

1.  Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials.

Authors:  Kennedy R Lees; Erich Bluhmki; Rüdiger von Kummer; Thomas G Brott; Danilo Toni; James C Grotta; Gregory W Albers; Markku Kaste; John R Marler; Scott A Hamilton; Barbara C Tilley; Stephen M Davis; Geoffrey A Donnan; Werner Hacke; Kathryn Allen; Jochen Mau; Dieter Meier; Gregory del Zoppo; D A De Silva; K S Butcher; M W Parsons; P A Barber; C Levi; C Bladin; G Byrnes
Journal:  Lancet       Date:  2010-05-15       Impact factor: 79.321

2.  Use of Strategies to Improve Door-to-Needle Times With Tissue-Type Plasminogen Activator in Acute Ischemic Stroke in Clinical Practice: Findings from Target: Stroke.

Authors:  Ying Xian; Haolin Xu; Barbara Lytle; Jason Blevins; Eric D Peterson; Adrian F Hernandez; Eric E Smith; Jeffrey L Saver; Steven R Messé; Mary Paulsen; Robert E Suter; Mathew J Reeves; Edward C Jauch; Lee H Schwamm; Gregg C Fonarow
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2017-01

Review 3.  2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.

Authors:  William J Powers; Alejandro A Rabinstein; Teri Ackerson; Opeolu M Adeoye; Nicholas C Bambakidis; Kyra Becker; José Biller; Michael Brown; Bart M Demaerschalk; Brian Hoh; Edward C Jauch; Chelsea S Kidwell; Thabele M Leslie-Mazwi; Bruce Ovbiagele; Phillip A Scott; Kevin N Sheth; Andrew M Southerland; Deborah V Summers; David L Tirschwell
Journal:  Stroke       Date:  2018-01-24       Impact factor: 7.914

4.  Time to Reperfusion and Treatment Effect for Acute Ischemic Stroke: A Randomized Clinical Trial.

Authors:  Puck S S Fransen; Olvert A Berkhemer; Hester F Lingsma; Debbie Beumer; Lucie A van den Berg; Albert J Yoo; Wouter J Schonewille; Jan Albert Vos; Paul J Nederkoorn; Marieke J H Wermer; Marianne A A van Walderveen; Julie Staals; Jeannette Hofmeijer; Jacques A van Oostayen; Geert J Lycklama À Nijeholt; Jelis Boiten; Patrick A Brouwer; Bart J Emmer; Sebastiaan F de Bruijn; Lukas C van Dijk; L Jaap Kappelle; Rob H Lo; Ewoud J van Dijk; Joost de Vries; Paul L M de Kort; J S Peter van den Berg; Boudewijn A A M van Hasselt; Leo A M Aerden; René J Dallinga; Marieke C Visser; Joseph C J Bot; Patrick C Vroomen; Omid Eshghi; Tobien H C M L Schreuder; Roel J J Heijboer; Koos Keizer; Alexander V Tielbeek; Heleen M den Hertog; Dick G Gerrits; Renske M van den Berg-Vos; Giorgos B Karas; Ewout W Steyerberg; H Zwenneke Flach; Henk A Marquering; Marieke E S Sprengers; Sjoerd F M Jenniskens; Ludo F M Beenen; René van den Berg; Peter J Koudstaal; Wim H van Zwam; Yvo B W E M Roos; Robert J van Oostenbrugge; Charles B L M Majoie; Aad van der Lugt; Diederik W J Dippel
Journal:  JAMA Neurol       Date:  2016-02       Impact factor: 18.302

5.  Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes.

Authors:  Gregg C Fonarow; Eric E Smith; Jeffrey L Saver; Mathew J Reeves; Deepak L Bhatt; Maria V Grau-Sepulveda; DaiWai M Olson; Adrian F Hernandez; Eric D Peterson; Lee H Schwamm
Journal:  Circulation       Date:  2011-02-10       Impact factor: 29.690

Review 6.  Streamlining Workflow for Endovascular Mechanical Thrombectomy: Lessons Learned from a Comprehensive Stroke Center.

Authors:  Hongjin Wang; Arthur Thevathasan; Richard Dowling; Steven Bush; Peter Mitchell; Bernard Yan
Journal:  J Stroke Cerebrovasc Dis       Date:  2017-06-01       Impact factor: 2.136

7.  Substantial Progress Yet Significant Opportunity for Improvement in Stroke Care in China.

Authors:  Zixiao Li; Chunjuan Wang; Xingquan Zhao; Liping Liu; Chunxue Wang; Hao Li; Haipeng Shen; Li Liang; Janet Bettger; Qing Yang; David Wang; Anxin Wang; Yuesong Pan; Yong Jiang; Xiaomeng Yang; Changqing Zhang; Gregg C Fonarow; Lee H Schwamm; Bo Hu; Eric D Peterson; Ying Xian; Yilong Wang; Yongjun Wang
Journal:  Stroke       Date:  2016-10-06       Impact factor: 7.914

8.  Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis.

Authors:  Jeffrey L Saver; Mayank Goyal; Aad van der Lugt; Bijoy K Menon; Charles B L M Majoie; Diederik W Dippel; Bruce C Campbell; Raul G Nogueira; Andrew M Demchuk; Alejandro Tomasello; Pere Cardona; Thomas G Devlin; Donald F Frei; Richard du Mesnil de Rochemont; Olvert A Berkhemer; Tudor G Jovin; Adnan H Siddiqui; Wim H van Zwam; Stephen M Davis; Carlos Castaño; Biggya L Sapkota; Puck S Fransen; Carlos Molina; Robert J van Oostenbrugge; Ángel Chamorro; Hester Lingsma; Frank L Silver; Geoffrey A Donnan; Ashfaq Shuaib; Scott Brown; Bruce Stouch; Peter J Mitchell; Antoni Davalos; Yvo B W E M Roos; Michael D Hill
Journal:  JAMA       Date:  2016-09-27       Impact factor: 56.272

9.  Stroke thrombolysis: save a minute, save a day.

Authors:  Atte Meretoja; Mahsa Keshtkaran; Jeffrey L Saver; Turgut Tatlisumak; Mark W Parsons; Markku Kaste; Stephen M Davis; Geoffrey A Donnan; Leonid Churilov
Journal:  Stroke       Date:  2014-03-13       Impact factor: 7.914

10.  Helsinki model cut stroke thrombolysis delays to 25 minutes in Melbourne in only 4 months.

Authors:  Atte Meretoja; Louise Weir; Melissa Ugalde; Nawaf Yassi; Bernard Yan; Peter Hand; Melinda Truesdale; Stephen M Davis; Bruce C V Campbell
Journal:  Neurology       Date:  2013-08-14       Impact factor: 9.910

View more
  1 in total

1.  Trial of a prehospital intervention with traditional Chinese medicine for acute stroke (TRACE): Protocol for a mixed-methods research study.

Authors:  Yuanyuan Chen; Ziyu Tian; Shuyan Wang; Hongmei Liu; Yanfang Liu; Wei Peng; Xinxing Lai; Dahe Qi; Lingbo Kong; Ying Gao
Journal:  Front Pharmacol       Date:  2022-08-29       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.